These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 31414756)

  • 1. High Urinary Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin are Associated with Increased Risk of Chronic Kidney Disease in Patients with Type 2 Diabetes.
    Stein CS; Carvalho JAM; Duarte MMMF; Comim FV; Premaor MO; Moretto MB; Moresco RN
    Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414756
    [No Abstract]   [Full Text] [Related]  

  • 2. Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as indicators of tubular damage in normoalbuminuric patients with type 2 diabetes.
    de Carvalho JA; Tatsch E; Hausen BS; Bollick YS; Moretto MB; Duarte T; Duarte MM; Londero SW; Premaor MO; Comim FV; Delanghe JR; Moresco RN
    Clin Biochem; 2016 Feb; 49(3):232-6. PubMed ID: 26519090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urine Markers of Kidney Tubule Cell Injury and Kidney Function Decline in SPRINT Trial Participants with CKD.
    Malhotra R; Katz R; Jotwani V; Ambrosius WT; Raphael KL; Haley W; Rastogi A; Cheung AK; Freedman BI; Punzi H; Rocco MV; Ix JH; Shlipak MG
    Clin J Am Soc Nephrol; 2020 Mar; 15(3):349-358. PubMed ID: 32111704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-acteyl-ß-D-glucosaminidase and kidney injury molecule-1: New predictors for long-term progression of chronic kidney disease in patients with heart failure.
    Jungbauer CG; Uecer E; Stadler S; Birner C; Buchner S; Maier LS; Luchner A
    Nephrology (Carlton); 2016 Jun; 21(6):490-8. PubMed ID: 26422793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression.
    Hsu CY; Xie D; Waikar SS; Bonventre JV; Zhang X; Sabbisetti V; Mifflin TE; Coresh J; Diamantidis CJ; He J; Lora CM; Miller ER; Nelson RG; Ojo AO; Rahman M; Schelling JR; Wilson FP; Kimmel PL; Feldman HI; Vasan RS; Liu KD; ;
    Kidney Int; 2017 Jan; 91(1):196-203. PubMed ID: 28029431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney Biomarkers and Decline in eGFR in Patients with Type 2 Diabetes.
    Garlo KG; White WB; Bakris GL; Zannad F; Wilson CA; Kupfer S; Vaduganathan M; Morrow DA; Cannon CP; Charytan DM
    Clin J Am Soc Nephrol; 2018 Mar; 13(3):398-405. PubMed ID: 29339356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of urinary kidney injury molecule-1, neutrophil gelatinase-associated lipocalin, and N-acetyl-β-D-glucosaminidase to predict chronic kidney disease progression and adverse outcomes.
    Lobato GR; Lobato MR; Thomé FS; Veronese FV
    Braz J Med Biol Res; 2017 Mar; 50(5):e6106. PubMed ID: 28380198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary levels of novel kidney biomarkers and risk of true worsening renal function and mortality in patients with acute heart failure.
    Sokolski M; Zymliński R; Biegus J; Siwołowski P; Nawrocka-Millward S; Todd J; Yerramilli MR; Estis J; Jankowska EA; Banasiak W; Ponikowski P
    Eur J Heart Fail; 2017 Jun; 19(6):760-767. PubMed ID: 28133864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kidney Damage Biomarkers and Incident Chronic Kidney Disease During Blood Pressure Reduction: A Case-Control Study.
    Zhang WR; Craven TE; Malhotra R; Cheung AK; Chonchol M; Drawz P; Sarnak MJ; Parikh CR; Shlipak MG; Ix JH;
    Ann Intern Med; 2018 Nov; 169(9):610-618. PubMed ID: 30357395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine Kidney Injury Biomarkers and Risks of Cardiovascular Disease Events and All-Cause Death: The CRIC Study.
    Park M; Hsu CY; Go AS; Feldman HI; Xie D; Zhang X; Mifflin T; Waikar SS; Sabbisetti VS; Bonventre JV; Coresh J; Nelson RG; Kimmel PL; Kusek JW; Rahman M; Schelling JR; Vasan RS; Liu KD; ;
    Clin J Am Soc Nephrol; 2017 May; 12(5):761-771. PubMed ID: 28254771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients.
    Żyłka A; Dumnicka P; Kuśnierz-Cabala B; Gala-Błądzińska A; Ceranowicz P; Kucharz J; Ząbek-Adamska A; Maziarz B; Drożdż R; Kuźniewski M
    Mediators Inflamm; 2018; 2018():7659243. PubMed ID: 30158836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Associations of Blood Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin with Progression from CKD to ESRD.
    Alderson HV; Ritchie JP; Pagano S; Middleton RJ; Pruijm M; Vuilleumier N; Kalra PA
    Clin J Am Soc Nephrol; 2016 Dec; 11(12):2141-2149. PubMed ID: 27852662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney Injury Marker 1 and Neutrophil Gelatinase-Associated Lipocalin in Chronic Kidney Disease.
    Castillo-Rodriguez E; Fernandez-Prado R; Martin-Cleary C; Pizarro-Sánchez MS; Sanchez-Niño MD; Sanz AB; Fernandez-Fernandez B; Ortiz A
    Nephron; 2017; 136(4):263-267. PubMed ID: 27771693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Worsening Renal Function in Patients With Acute Heart Failure Undergoing Aggressive Diuresis Is Not Associated With Tubular Injury.
    Ahmad T; Jackson K; Rao VS; Tang WHW; Brisco-Bacik MA; Chen HH; Felker GM; Hernandez AF; O'Connor CM; Sabbisetti VS; Bonventre JV; Wilson FP; Coca SG; Testani JM
    Circulation; 2018 May; 137(19):2016-2028. PubMed ID: 29352071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary calprotectin, kidney injury molecule-1, and neutrophil gelatinase-associated lipocalin for the prediction of adverse outcome in pediatric acute kidney injury.
    Westhoff JH; Seibert FS; Waldherr S; Bauer F; Tönshoff B; Fichtner A; Westhoff TH
    Eur J Pediatr; 2017 Jun; 176(6):745-755. PubMed ID: 28409285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary calprotectin, NGAL, and KIM-1 in the differentiation of primarily inflammatory vs. non-inflammatory stable chronic kidney diseases.
    Seibert FS; Sitz M; Passfall J; Haesner M; Laschinski P; Buhl M; Bauer F; Rohn B; Babel N; Westhoff TH
    Ren Fail; 2021 Dec; 43(1):417-424. PubMed ID: 33663323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients.
    Kim SS; Song SH; Kim IJ; Yang JY; Lee JG; Kwak IS; Kim YK
    Diabetes Res Clin Pract; 2012 Aug; 97(2):251-7. PubMed ID: 22440044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical application of neutrophil gelatinase-associated lipocalin in the revised chronic kidney disease classification.
    Xiang D; Zhang H; Bai J; Ma J; Li M; Gao J; Wang C
    Int J Clin Exp Pathol; 2014; 7(10):7172-81. PubMed ID: 25400814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary Biomarkers at the Time of AKI Diagnosis as Predictors of Progression of AKI among Patients with Acute Cardiorenal Syndrome.
    Chen C; Yang X; Lei Y; Zha Y; Liu H; Ma C; Tian J; Chen P; Yang T; Hou FF
    Clin J Am Soc Nephrol; 2016 Sep; 11(9):1536-1544. PubMed ID: 27538426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of urinary neutrophil gelatinase-associated lipocalin, clusterin, and cystatin C in predicting diabetic kidney disease and diabetic microalbuminuria: a consecutive cohort study.
    Zeng XF; Lu DX; Li JM; Tan Y; Li Z; Zhou L; Xi ZQ; Zhang SM; Duan W
    BMC Nephrol; 2017 Jul; 18(1):233. PubMed ID: 28701152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.